Home / Funds / Great Point Partners, LLC
Great Point Partners, LLC
Every short position this fund has disclosed, market by market.
0 open positions
0 Markets
August 5, 2021 Last disclosure
This fund discloses no open short position today.
Get the moves on Great Point Partners, LLC by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| August 5, 2021 | Pharming Group N.V. | Netherlands | 0.47% | |
| August 3, 2021 | Pharming Group N.V. | Netherlands | 0.85% | |
| July 30, 2021 | Pharming Group N.V. | Netherlands | 0.95% | |
| July 8, 2021 | Pharming Group N.V. | Netherlands | 1.07% | |
| July 7, 2021 | Pharming Group N.V. | Netherlands | 1.73% | |
| December 11, 2020 | Pharma MAR, S.A. | Spain | 0.42% | |
| December 10, 2020 | Pharma MAR, S.A. | Spain | 0.50% | |
| December 2, 2020 | Pharming Group N.V. | Netherlands | 1.86% | |
| October 16, 2020 | Pharma MAR, S.A. | Spain | 0.62% | |
| July 16, 2020 | Pharma MAR, S.A. | Spain | 0.53% | |
| March 13, 2020 | Pharming Group N.V. | Netherlands | 1.90% | |
| May 16, 2019 | Pharming Group N.V. | Netherlands | 1.60% | |
| May 15, 2019 | Pharming Group N.V. | Netherlands | 1.44% | |
| March 4, 2019 | Pharming Group N.V. | Netherlands | 1.31% | |
| March 1, 2019 | Pharming Group N.V. | Netherlands | 1.02% | |
| February 28, 2019 | Pharming Group N.V. | Netherlands | 0.98% | |
| February 21, 2019 | Pharming Group N.V. | Netherlands | 0.80% | |
| November 8, 2018 | Pharming Group N.V. | Netherlands | 0.74% | |
| October 25, 2018 | Pharming Group N.V. | Netherlands | 0.61% | |
| September 19, 2018 | Pharming Group N.V. | Netherlands | 0.56% | |
| September 18, 2018 | Pharming Group N.V. | Netherlands | 0.77% | |
| July 26, 2018 | Pharming Group N.V. | Netherlands | 0.82% | |
| July 24, 2018 | Pharming Group N.V. | Netherlands | 0.62% | |
| July 23, 2018 | Pharming Group N.V. | Netherlands | 0.54% | |
| March 10, 2017 | Innate Pharma | France | 0.41% | March 13, 2017 |
| March 2, 2017 | Innate Pharma | France | 0.57% | March 13, 2017 |
| February 23, 2017 | Innate Pharma | France | 0.69% | March 13, 2017 |
| February 7, 2017 | Innate Pharma | France | 0.79% | March 13, 2017 |
| November 9, 2016 | Innate Pharma | France | 0.93% | March 13, 2017 |
| October 31, 2016 | Ablynx | Belgium | 0.57% | November 3, 2016 |
| October 26, 2016 | Innate Pharma | France | 0.83% | March 13, 2017 |
| October 26, 2016 | Ablynx | Belgium | 0.66% | October 31, 2016 |
| October 4, 2016 | Innate Pharma | France | 0.74% | March 13, 2017 |
| September 14, 2016 | Innate Pharma | France | 0.60% | March 13, 2017 |
| August 22, 2016 | Ablynx | Belgium | 0.70% | October 26, 2016 |
| August 18, 2016 | Ablynx | Belgium | 0.66% | August 22, 2016 |
| August 17, 2016 | Ablynx | Belgium | 0.57% | August 18, 2016 |
| July 18, 2016 | Innate Pharma | France | 0.51% | March 13, 2017 |
| January 28, 2014 | AB Science | France | 0.13% | January 30, 2014 |
| November 14, 2013 | AB Science | France | 0.61% | January 30, 2014 |
| October 17, 2013 | AB Science | France | 0.53% | January 30, 2014 |
Download 41 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Great Point Partners, LLC, data as at August 5, 2021, https://www.quivad.com/detenteur/great-point-partners-llc